NVO (Novo Nordisk AS) Operating Cash Flow per Share : $4.28 (TTM As of Mar. 2025)

View and export this data going back to 1981. Start your Free Trial

What is Novo Nordisk AS Operating Cash Flow per Share?

Novo Nordisk AS's operating cash flow per share for the three months ended in Mar. 2025 was $0.80. Novo Nordisk AS's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was $4.28.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Novo Nordisk AS was 41.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 31.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 24.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Novo Nordisk AS's Operating Cash Flow per Share or its related term are showing as below:

NVO' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -46.4 Med: 16.8 Max: 136.2
Current: 31.4

During the past 13 years, Novo Nordisk AS's highest 3-Year average Operating Cash Flow per Share Growth Rate was 136.20% per year. The lowest was -46.40% per year. And the median was 16.80% per year.

NVO's 3-Year OCF Growth Rate is ranked better than
75.58% of 778 companies
in the Drug Manufacturers industry
Industry Median: 8.7 vs NVO: 31.40

Novo Nordisk AS Operating Cash Flow per Share Historical Data

The historical data trend for Novo Nordisk AS's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Operating Cash Flow per Share Chart

Novo Nordisk AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

1.82

1.81

2.47

3.55

3.81

Novo Nordisk AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.47	1.63	1.46	0.39	0.80

Competitive Comparison of Novo Nordisk AS's Operating Cash Flow per Share

For the Drug Manufacturers - General subindustry, Novo Nordisk AS's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novo Nordisk AS's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novo Nordisk AS's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Novo Nordisk AS's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Novo Nordisk AS Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Novo Nordisk AS's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	16984.878	/	4463.000
	=	3.81

Novo Nordisk AS's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	3564.275	/	4446.400
	=	0.80

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.28

Novo Nordisk AS Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (NYSE:NVO) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

NONOF:USA NOVOB:Mexico NVO:Mexico 0TDD:UK NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV0:Germany NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany NVON:Canada N1VO34:Brazil NOV:Bulgaria NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, 2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.